Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in:

04-05-2024 | Hepatic Encephalopathy | Profiles and Perspectives

Increasing Healthcare System Empathy for Patients with Advanced Liver Disease: My Top 10 Lessons in Palliative Hepatology

Author: Nneka N. Ufere

Published in: Digestive Diseases and Sciences | Issue 6/2024

Login to get access

Excerpt

I am a transplant hepatologist who has a specific clinical and research focus on palliative hepatology. I have defined palliative hepatology as follows: Holistic care given to patients with advanced liver disease and their families to improve their quality of life over the entirety of their illness trajectory, both to and through transplantation and at the end of life. …
Literature
1.
Schomerus G, Leonhard A, Manthey J et al. The stigma of alcohol-related liver disease and its impact on healthcare. J Hepatol 2022;77:516–524.CrossRefPubMed
2.
American Association for the Study of Liver Diseases, European Association for the Study of the Liver, Latin American Association for the Study of the Liver et al. Ending stigmatizing language in alcohol and liver disease: A liver societies’ statement. Hepatology 2023;78:1682–1683.
3.
Centers for Disease Control and Prevention National Center for Injury Prevention and Control. Web-Based Injury Statistics Query and Reporting System (WISQARS), Vol 2021. CDC: Atlanta, 2017.
4.
Ufere NN, Donlan J, Indriolo T et al. Burdensome transitions of care for patients with end-stage liver disease and their caregivers. Dig Dis Sci 2021;66:2942–2955.CrossRefPubMed
5.
Kaplan A, Comisar L, Ufere NN et al. Understanding prognosis: Discrepancy in prognosis estimates between patients with cirrhosis and their hepatologists. Clin Gastroenterol Hepatol 2023;21:1005–1012.CrossRefPubMed
6.
Gustot T, Stadlbauer V, Laleman W et al. Transition to decompensation and acute-on-chronic liver failure: role of predisposing factors and precipitating events. J Hepatol 2021;75(Suppl 1):S36–S48.CrossRefPubMed
7.
Peng JK, Hepgul N, Higginson IJ et al. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24–36.CrossRefPubMed
8.
9.
Patel AA, Tapper EB, Kanwal F et al. Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus. Hepatol Commun 2023;7:e0135.CrossRefPubMedPubMedCentral
10.
Lago-Hernandez C, Nguyen NH, Khera R et al. Cost-related nonadherence to medications among US adults with chronic liver diseases. Mayo Clin Proc 2021;96:2639–2650.CrossRefPubMed
11.
Bajaj JS, Wade JB, Gibson DP et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 2011;106:1646–1653.CrossRefPubMedPubMedCentral
12.
13.
Philip G, Hookey L, Richardson H et al. Alcohol-associated liver disease is now the most common indication for liver transplant waitlisting among young American adults. Transplantation 2022;106:2000–2005.CrossRefPubMed
14.
15.
16.
Kwong AJ, Devuni D, Wang C et al. Outcomes of liver transplantation among older recipients with nonalcoholic steatohepatitis in a large multicenter US Cohort: The re-evaluating age limits in transplantation consortium. Liver Transpl 2020;26:1492–1503.CrossRefPubMedPubMedCentral
17.
Kochar B, Ufere NN, Ritchie CS et al. The 5Ms of geriatrics in gastroenterology: The path to creating age-friendly care for older adults with inflammatory bowel diseases and cirrhosis. Clin Transl Gastroenterol 2022;13:e00445.CrossRefPubMedPubMedCentral
18.
Su F, Yu L, Berry K et al. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes, and transplant-related survival benefit. Gastroenterology 2016;150:441–453.CrossRefPubMed
19.
Ufere NN, El-Jawahri A, Ritchie C et al. Promoting prognostic understanding and health equity for patients with advanced liver disease: Using “best case/worst case.” Gastroenterology 2023;164:171–176.CrossRefPubMed
20.
Saly DL, Allegretti AS, Ufere NN, et al. The SILK Collaborative: A multidisciplinary approach to serious illness communication for patients with liver failure and acute kidney injury. Kidney360 2024 Feb 7. Online ahead of print.
21.
Kaplan A, Fortune B, Ufere N et al. National trends in location of death in patients with end-stage liver disease. Liver Transpl 2021;27:165–176.CrossRefPubMed
22.
Macken L, Bremner S, Gage H et al. Randomised clinical trial: Palliative long-term abdominal drains vs large-volume paracentesis in refractory ascites due to cirrhosis. Aliment Pharmacol Ther 2020;52:107–122.CrossRefPubMed
23.
Tandon P, Walling A, Patton H et al. AGA Clinical Practice Update on palliative care management in cirrhosis: Expert review. Clin Gastroenterol Hepatol 2021;19:646–656.CrossRefPubMed
24.
Rogal S, Hansen L, Patel A et al. AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology 2022;76:819–853.CrossRefPubMed
25.
Verma S, Hingwala J, Low JTS et al. Palliative clinical trials in advanced chronic liver disease: Challenges and opportunities. J Hepatol 2023;79:1236–1253.CrossRefPubMed
26.
Verma M, Kosinski AS, Volk ML et al. Introducing palliative care within the treatment of end-stage liver disease: The study protocol of a cluster randomized controlled trial. J Palliat Med 2019;22:34–43.CrossRefPubMed
Metadata
Title
Increasing Healthcare System Empathy for Patients with Advanced Liver Disease: My Top 10 Lessons in Palliative Hepatology
Author
Nneka N. Ufere
Publication date
04-05-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2024
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08406-9

Other articles of this Issue 6/2024

Triglycerides: A Sensitizer but Not a Trigger for Hypertriglyceridemic Acute Pancreatitis

DEAD-Box Helicase 17 circRNA (circDDX17) Reduces Sorafenib Resistance and Tumorigenesis in Hepatocellular Carcinoma

Assessment of the Learning Curve for a Single-Use Disposable Duodenoscope

Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study

Response to “Optimal Timing of Endoscopy in Patients Taking Anticoagulants with Upper Gastrointestinal Bleeding”

An Asynchronous Hypopharyngeal Carcinoma Removed en bloc via Endoscopic Submucosal Dissection in a Postoperative Patient with Hypopharyngeal Cancer

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar
Image Credits